Sonrotoclax
Product Specifications
CAS Number
2383086-06-2
Synonyms
BGB-11417
Target
Bcl-2
Applications
Apoptosis
Molecular Formula
C49H59N7O7S
Additionnal Information
Sonrotoclax (BGB-11417) is a highly potent, orally active and selective inhibitor of Bcl2. Sonrotoclax demonstrates increased potency along with in vitro and in vivo inhibitory activity against both WT Bcl-2 and the G101V mutant. Bcl-xL Sonrotoclax has effective cell killing effect against a variety of lymphoma and leukemia cell lines.
More Discoveries
Explore Other Products
Browse additional items from our catalog
13851091 4x 500 ng
C14orf21-set siRNA/shRNA/RNAi Lentivector (Human)
Sign In for Pricing
View Details 
MBS049549 Inquire
Chicken Nuclear Receptor Subfamily 3, Group C, Member 1 ELISA Kit
Sign In for Pricing
View Details 
041190-ML550 100 µL
RPL11, NT (RPL11, 60S ribosomal protein L11, CLL-associated antigen KW-12) (MaxLight 550) discontinued
Sign In for Pricing
View Details 